Hepatitis is a huge global health problem, with nearly 400 million people worldwide affected, resulting in over 1.4 million deaths per year. The project aims to develop a prototype and establish the reliability, stability and sensitivity of the sensor in preparation for its commercialisation. It is estimated that if the sensor is produced in large quantities, each device could cost as little as £1.
Supported by the UK’s Newton Fund and led by Biovici, this multi-partner project brings together NPL, the University of Chongqing, Swansea University and CTN to develop this new diagnostic technology.
Our research and measurement solutions support innovation and product development. We work with companies to deliver business advantage and commercial success. Contact our Customer Services team on +44 20 8943 7070